Empirical Finance
DXCM icon

Empirical Finance’s DexCom DXCM Stock Holding History

Empirical Finance’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15M Buy
13,285
+313
+2% +$26K 0.05% 301
2026
Q2 		$874K Buy
12,972
+461
+4% +$30.7K 0.04% 338
2026
Q1 		$786K Sell
12,511
-15
-0.1% -$1.04K 0.04% 341
2025
Q4 		$831K Sell
12,526
-580
-4% -$37.5K 0.04% 323
2025
Q3 		$882K Buy
13,106
+132
+1% +$10.4K 0.04% 337
2025
Q2 		$1.13M Buy
12,974
+94
+0.7% +$7.37K 0.06% 270
2025
Q1 		$880K Buy
12,880
+346
+3% +$28.2K 0.05% 300
2024
Q4 		$975K Sell
12,534
-85
-0.7% -$6.29K 0.06% 276
2024
Q3 		$846K Buy
12,619
+364
+3% +$29.9K 0.05% 308
2024
Q2 		$1.39M Sell
12,255
-966
-7% -$122K 0.09% 190
2024
Q1 		$1.83M Buy
13,221
+462
+4% +$58.1K 0.11% 169
2023
Q4 		$1.58M Buy
12,759
+117
+0.9% +$12K 0.11% 172
2023
Q3 		$1.18M Buy
12,642
+1,333
+12% +$150K 0.09% 209
2023
Q2 		$1.45M Buy
11,309
+1,253
+12% +$152K 0.11% 162
2023
Q1 		$1.17M Buy
10,056
+597
+6% +$66.8K 0.11% 174
2022
Q4 		$1.07M Buy
9,459
+851
+10% +$93.4K 0.11% 178
2022
Q3 		$693K Buy
8,608
+1,587
+23% +$134K 0.08% 234
2022
Q2 		$523K Buy
7,021
+433
+7% +$39.5K 0.07% 269
2022
Q1 		$843K Buy
6,588
+1,512
+30% +$165K 0.09% 199
2021
Q4 		$681K Buy
5,076
+1,168
+30% +$168K 0.08% 226
2021
Q3 		$534K Buy
3,908
+308
+9% +$38.8K 0.08% 251
2021
Q2 		$384K Buy
3,600
+640
+22% +$61.5K 0.06% 289
2021
Q1 		$274K Hold
2,960
– – 0.05% 283
2020
Q4 		$274K Buy
2,960
+700
+31% +$62.5K 0.05% 283
2020
Q3 		$233K Buy
+2,260
New +$236K 0.05% 255

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Empirical Finance's DXCM Position: Q3 2026 in Review

Empirical Finance increased its DexCom (DXCM) stake by 2.4% in Q3 2026, buying an estimated $26K and bringing the position to 13,285 shares worth $1.15M. The position accounts for 0.05% of the portfolio, ranked #301.

Empirical Finance first reported a position in DXCM in Q3 2020 and has held it in 25 quarters since. The position peaked at $1.83M in Q1 2024. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Empirical Finance held 13,285 shares of DexCom worth $1.15M as of Q3 2026.
  • Empirical Finance bought 313 DexCom shares in Q3 2026, an estimated $26K.
  • DexCom made up 0.05% of Empirical Finance's portfolio in Q3 2026, its #301 holding.
  • Empirical Finance first reported a position in DexCom in Q3 2020 and has held it in 25 quarters since.
  • Empirical Finance's DexCom position peaked at $1.83M in Q1 2024.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Empirical Finance's 13F filing for Q3 2026, filed 13 Nov 2026.